Join to View Full Profile
20 Duke Medicine CirDurham, NC 27710
Phone+1 888-275-3853
Dr. Previs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2013 - 2017
Duke University HospitalResidency, Obstetrics and Gynecology, 2009 - 2013
University of Virginia School of MedicineClass of 2009
The University of Texas Graduate School of Biological SciencesMS
Certifications & Licensure
NC State Medical License 2009 - 2026
TX State Medical License 2015 - 2019
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- A Study of LY3405105 in Participants With Advanced Cancer Start of enrollment: 2019 Jan 31
- Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients Start of enrollment: 2019 Aug 08
Publications & Presentations
PubMed
- Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression.Amma Asare, Rebecca Ann Previs, Daniel Spinosa, Bryan Fellman, Amelia L Scott
Gynecologic Oncology. 2025-03-01 - 1 citationsMolecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.Aine Clements, Danielle Enserro, Kyle C Strickland, Rebecca Previs, Daniela Matei
Gynecologic Oncology. 2025-02-01 - From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates.Heidi C Ko, Kyle C Strickland, Dana Jaggessarsingh, Alicia Dillard, Michelle Green
Frontiers in Oncology. 2025-01-01
Journal Articles
- Differential Expression of Immune Related Genes in High-Grade Ovarian Serous CarcinomaRebecca A Previs, Angeles Alvarez Secord, Gynecologic Oncology
Press Mentions
Diagnostics, Access, Therapies on Minds Ahead of ASCOApril 18th, 2025- Outcomes4Me Inc.: Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-Low Awareness for Metastatic Breast Cancer PatientsNovember 26th, 2024
- What Is HER2? What Does HER2-Low Mean for Treatment Options?October 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
